FDA Fast-Tracks Review of Overdose Drug Naloxone for Use Without Prescription
New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA
US FDA Has Model Drug Facts Labels For OTC Naloxone, Needs Switch Proposals
OTC Naloxone One Step Closer as Harm Reduction Therapeutics Initiates a Rolling Submission of its New Drug Application to U.S. FDA for RiVive™ for Emergency Treatment of Opioid Overdose